Cigall Kadoch, PHD

Dana-Farber Cancer Institute – Associate Professor, Pediatric Oncology

Harvard Medical School – Affiliate Faculty of Biological Chemistry and Molecular Biology

Broad Institute of MIT and Harvard – Institute Member and Epigenomics Program Co-Director

Dr. Kadoch established her independent laboratory in 2014, at age 28, and is one of the youngest scientists ever appointed to the Harvard Medical School faculty immediately following completion of her PhD studies in Cancer Biology at Stanford University. Her work has centered on unraveling the mechanisms of large, highly intricate nuclear protein machines called BAF chromatin remodeling complexes, which are among the most frequently mutated entities in human cancer. Her work has led to new classes of drugs to correct abnormal gene expression caused by these defective complexes. She has quickly become a leading expert in chromatin and gene regulation and is internationally recognized for her groundbreaking studies in these areas.